Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

公司动态 - Rocket Pharmaceuticals公司于周五宣布已撤回其针对一种罕见遗传性血液疾病的实验性基因疗法的美国上市申请 [1]